Rothbaum Wayne P. 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Rothbaum Wayne P.
Director
Transactions
- Purchase
Common Stock
2024-02-20$9.15/sh+5,000,000$45,750,000→ 28,067,333 total(indirect: By LLC)
Footnotes (3)
- [F1]Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer.
- [F2]The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC.
- [F3]Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.